drugset / Trial / NCT02454868
Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade
NaSingle-groupOpen-labelSupportive care
Summary
Introduction: remifentanil's optimal dose for children intubation without neuromuscular blockade is unknown. Method: phase IV adaptative trial using Dixon's up-and-down method for modeling remifentanil's dose-response curve for adequate intubation conditions as defined by previous studies.
Timeline
- Start
- 2016-07
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remifentanil | Small molecule | 2 ug/kg | — |
Indications
No indication recorded.